Showing results (1721-1730 of 1,810) with videos related to
Sort By:
Pageof 181
Nature Communications|August 5, 2025
DDX41 resolves G-quadruplexes to maintain erythroid genome integrity and prevent cGAS-mediated cell deathHonghao Bi, Kehan Ren, Pan Wang, et al.Genome Research|January 8, 2024
High-throughput and genome-scale targeted mutagenesis using CRISPR in a nonmodel multicellular organism, Bombyx moriSanyuan Ma, Tong Zhang, Ruolin Wang, et al.Genes, Chromosomes & Cancer|October 23, 2021
Clinicopathological features and resistance mechanisms in HIP1-ALK-rearranged lung cancer: A multicenter studyJin Kang, Qiu-Mei Deng, Kai-Cheng Peng, et al.The American Journal of Pathology|February 9, 2020
mTORC2 Signaling Is Necessary for Timely Liver Regeneration after Partial HepatectomyMeng Xu, Haichuan Wang, Jingxiao Wang, et al.The American Journal of Pathology|February 23, 2019
TEA Domain Transcription Factor 4 Is the Major Mediator of Yes-Associated Protein Oncogenic Activity in Mouse and Human HepatoblastomaJie Zhang, Pin Liu, Junyan Tao, et al.Nature Communications|January 31, 2024
Experimentally validated design principles of heteroatom-doped-graphene-supported calcium single-atom materials for non-dissociative chemisorption solid-state hydrogen storageYong Gao, Zhenglong Li, Pan Wang, et al.Translational Vision Science & Technology|September 17, 2024
Drug-Related Keratitis: A Real-World FDA Adverse Event Reporting System Database StudyShi-Nan Wu, Xiao-Dong Chen, Qing-He Zhang, et al.Free Radical Biology & Medicine|January 3, 2024
Interventing mitochondrial PD-L1 suppressed IFN-γ-induced cancer stemness in hepatocellular carcinoma by sensitizing sorafenib-induced ferroptosisTing Li, Hai-Yan Huang, Bo Qian, et al.Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae|May 17, 2016
[Association of Insulin Resistance and β Cell Function with Lipid Metabolism in Middle-aged and Elderly Hui and Han Populations]Shu-ya Li, Min Jiang, Tian-yu Yao, et al.Discover Oncology|June 13, 2025
Stereotactic body radiation therapy (SBRT) increases anti-PD-1 antitumor activity by enhancing the tumor immune microenvironment in mice with metastatic hepatocellular carcinomaKe Xu, Tao Gu, Ke Su, et al.Pageof 181